Search research articles
Contact Us
Filters
Showing results (381-390 of 681) with videos related to
Page
of 69
Sort By:
AIDS (London, England)
|
December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients
A N Phillips, C Pradier, A Lazzarin, et al.
Infection
|
June 7, 2014
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
A Mocroft, P Reiss, A Rakhmanova, et al.
The Journal of Infectious Diseases
|
February 28, 2015
Factors Associated With Plasma IL-6 Levels During HIV Infection
Álvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
AIDS (London, England)
|
June 17, 1999
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group
A Mocroft, O Kirk, S E Barton, et al.
The Journal of Infectious Diseases
|
July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts
Veronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
October 15, 2011
Changes in brain activation to food pictures after adjustable gastric banding
Jared M Bruce, Laura Hancock, Amanda Bruce, et al.
Lancet (London, England)
|
July 11, 2003
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft, B Ledergerber, C Katlama, et al.
Clinical and Diagnostic Laboratory Immunology
|
April 9, 2005
Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis
Pernille Ravn, Martin E Munk, Ase B Andersen, et al.
HIV Medicine
|
January 18, 2008
Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999
A Mocroft, A Horban, B Clotet, et al.
AIDS Research and Human Retroviruses
|
October 13, 2005
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection
A Mocroft, A N Phillips, V Soriano, et al.
Page
of 69
Search research articles
Search
Showing results (381-390 of 681) with videos related to
Sort By:
Page
of 69
AIDS (London, England)
|
December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients
A N Phillips, C Pradier, A Lazzarin, et al.
Infection
|
June 7, 2014
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
A Mocroft, P Reiss, A Rakhmanova, et al.
The Journal of Infectious Diseases
|
February 28, 2015
Factors Associated With Plasma IL-6 Levels During HIV Infection
Álvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
AIDS (London, England)
|
June 17, 1999
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group
A Mocroft, O Kirk, S E Barton, et al.
The Journal of Infectious Diseases
|
July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts
Veronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
October 15, 2011
Changes in brain activation to food pictures after adjustable gastric banding
Jared M Bruce, Laura Hancock, Amanda Bruce, et al.
Lancet (London, England)
|
July 11, 2003
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft, B Ledergerber, C Katlama, et al.
Clinical and Diagnostic Laboratory Immunology
|
April 9, 2005
Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis
Pernille Ravn, Martin E Munk, Ase B Andersen, et al.
HIV Medicine
|
January 18, 2008
Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999
A Mocroft, A Horban, B Clotet, et al.
AIDS Research and Human Retroviruses
|
October 13, 2005
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection
A Mocroft, A N Phillips, V Soriano, et al.
Page
of 69